Salvaging sepsis-associated atypical hemolytic uremic syndrome with terminal complement blockade: A case report. [PDF]
Qiu Y +5 more
europepmc +1 more source
Diabetes combined with ischemic stroke (DMIS) exacerbates brain infarct size and neuronal damage compared to nondiabetic ischemic stroke (IS). This study reveals that microRNA‐34a (miR‐34a) plays a key role in DMIS pathogenesis: miR‐34a directly targets and suppresses brain‐derived neurotrophic factor (BDNF) and Sine oculis homeobox 3 (SIX3), promoting
Ling Zhao +5 more
wiley +1 more source
Sustained remission with eculizumab in refractory lupus nephritis with atypical haemolytic uraemic syndrome. [PDF]
Thomson B, Nicholls K.
europepmc +1 more source
Phagocyte proteinases in multiple trauma and sepsis [PDF]
Fritz, Hans +4 more
core +1 more source
Advances and Challenges in Micro/Nanocarrier‐Based Dermal Drug Delivery Systems for Acne Treatment
Topical acne treatment faces challenges from skin barriers and complex causes. Micro/nanocarriers improve drug delivery by enhancing bioavailability, targeting, and duration. Combining carriers creates synergistic effects for systematic intervention.
Jintao Yang +7 more
wiley +1 more source
Ravulizumab in NMOSD with associated interstitial pneumonitis in a 59-year-old female patient: a case report. [PDF]
Neundorf A, Dittrich R.
europepmc +1 more source
Despite significant advances, most academic research fails to result in medical products that benefit patients. This guide shares five key steps to help researchers close that gap: set clear goals, test thoroughly, protect ideas, build diverse teams, and partner with industry.
Cristina Oldani +4 more
wiley +1 more source
The Effectiveness of Chelating Solutions and Photodynamic Therapy in Inactivating Bacterial Lipopolysaccharides During Endodontic Therapy. [PDF]
Oda DF +6 more
europepmc +1 more source
Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]
Nguyen MD +10 more
europepmc +1 more source
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary. [PDF]
Arrais C, Carnelutto N, Reyes J.
europepmc +1 more source

